Cargando…

COVID-19: Possible Impact of the Genetic Background in IFNL Genes on Disease Outcomes

Detalles Bibliográficos
Autor principal:	Mihm, Sabine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251566/ https://www.ncbi.nlm.nih.gov/pubmed/32344401 http://dx.doi.org/10.1159/000508076

Ejemplares similares

Hepatic IFNL4 Gene Activation in Hepatocellular Carcinoma Patients with Regard to Etiology
por: Huschka, Henriette, et al.
Publicado: (2021)

Hepatic Interferon-λ3 (IFNL3) Gene Expression Reveals Not to Be Attenuated in Non-Favorable IFNL3 rs4803217 or IFNL4 rs368234815 Minor Allele Carriers in Chronic Hepatitis C
por: Amanzada, Ahmad, et al.
Publicado: (2015)

Interferon-lambda (IFNL) germline variations and their significance for HCC and PDAC progression: an analysis of The Cancer Genome Atlas (TCGA) data
por: Huschka, Henriette, et al.
Publicado: (2020)

Interferon-λ(4) (IFNL4) Transcript Expression in Human Liver Tissue Samples
por: Amanzada, Ahmad, et al.
Publicado: (2013)

IFNL4 genetic variant can predispose to COVID-19
por: Saponi-Cortes, Jose Maria R., et al.
Publicado: (2021)

Viral genotypes and human rs12979860 polymorphism of the IFNL3 gene in hepatitis C infected patients in Southern Brazil
por: Frizon, Kelen, et al.
Publicado: (2014)

Variants of IFNL4 Gene in Amazonian and Northern Brazilian Populations
por: Angelim, Carolina Cabral, et al.
Publicado: (2023)

Takotsubo Syndrome in COVID-19 Requires Elucidation of the Pathophysiological Background
por: Finsterer, Josef, et al.
Publicado: (2022)

Friedreich ataxia in COVID-19 time: current impact and future possibilities
por: Schirinzi, Tommaso, et al.
Publicado: (2021)

Is it possible to eradicate the covid-19 or not?
por: Khezri, Rozhan, et al.
Publicado: (2022)

The impact of COVID-19 lockdown on children and adolescents and possible solutions: a perspective
por: Kumar, Nomesh, et al.
Publicado: (2021)

Unravel the genetic background of noncompaction before relating it with myocardial hypoperfusion
por: Stöllberger, Claudia, et al.
Publicado: (2020)

Impact of COVID-19 on neonatal outcomes
por: Siddhi, P.S., et al.
Publicado: (2022)

IFNL4 and IFNL3 Associated Polymorphisms Strongly Influence the Spontaneous IFN-Alpha Receptor-1 Expression in HCV-Infected Patients
por: Bordi, Licia, et al.
Publicado: (2015)

PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus‐related diseases
por: De Re, Valli, et al.
Publicado: (2020)

The 2019 Coronavirus Disease (COVID-19): Possible Psychological Effects and Necessary Actions
por: Goudarzian, Amir Hossein
Publicado: (2021)

Dysgeusia in COVID-19: Possible Mechanisms and Implications
por: Lozada-Nur, Francina, et al.
Publicado: (2020)

Will COVID-19 vaccine equity be possible in India?
por: Mathivathanan, Kanagavalli
Publicado: (2021)

Possible agent for COVID-19 treatment: Rifampicin
por: Aydin, Ozlem Celik, et al.
Publicado: (2022)

Vibrio cholerae O1 Isolate with Novel Genetic Background, Thailand–Myanmar
por: Okada, Kazuhisa, et al.
Publicado: (2013)

Response to the letter to the editor: unravel the genetic background of noncompaction before relating it with myocardial hypoperfusion
por: Cerar, Andraz, et al.
Publicado: (2020)

Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients
por: Pedergnana, Vincent, et al.
Publicado: (2019)

Possible role of zinc (Zn) as an adjunctive therapy in gastrointestinal symptoms of COVID-19 infectious disease
por: Abbasinazari, Mohammad
Publicado: (2020)

Comment on: should lung ultrasound be always performed in older patients with possible COVID-19 disease
por: Brockhattingen, Kristoffer Kittelmann, et al.
Publicado: (2022)

COVID-19 and Parkinson’s disease: a casual association or a possible second hit in neurodegeneration?
por: Cavallieri, Francesco, et al.
Publicado: (2021)

Gene–disease association with human IFNL locus polymorphisms extends beyond hepatitis C virus infections
por: Chinnaswamy, S
Publicado: (2016)

Consider the genetic and myopathic background, familial occurrence, and alternative definitions of left ventricular hypertrabeculation/noncompaction
por: Finsterer, Josef, et al.
Publicado: (2015)

The Eye: A Possible New Route of Infection in COVID-19
por: Abobaker, Anis, et al.
Publicado: (2020)

Colchicine as a possible therapeutic option in COVID-19 infection
por: Parra-Medina, Rafael, et al.
Publicado: (2020)

Possible Controlling Measures of Panic Buying During COVID-19
por: Arafat, S. M. Yasir, et al.
Publicado: (2020)

Hyperglycemia and the novel Covid-19 infection: Possible pathophysiologic mechanisms
por: Ilias, Ioannis, et al.
Publicado: (2020)

Periodontal pocket and COVID-19: Could there be a possible link?
por: Elisetti, Nirupa
Publicado: (2021)

Answers to the comments on “air born possibility of covid19 virus”
por: Vosoughi, Mehdi, et al.
Publicado: (2021)

Dengue After COVID-19 Vaccination: Possible and Might be Missed
por: Kebayoon, Amnuay, et al.
Publicado: (2021)

Possibility of Relapse of COVID19 in Asymptomatic Cases and Risk Assessment
por: Syal, Kirtimaan
Publicado: (2022)

The impact of atrial fibrillation on outcomes in patients hospitalized with COVID-19
por: Agarwal, Siddharth, et al.
Publicado: (2023)

COVID-19 highlights health inequalities in individuals from black and minority ethnic backgrounds within the United Kingdom
por: Wheatle, Monique
Publicado: (2021)

Genetic variation of allergic disease is associated with the susceptibility to COVID-19
por: Xu, Yaqi, et al.
Publicado: (2022)

Reply to: Consider the genetic and myopathic background, familial occurrence, and alternative definitions of left ventricular hypertrabeculation/noncompaction
por: Ali, Sulafa K.M.
Publicado: (2015)

Possible Neurological and Mental Outcomes of COVID-19 Infection: A Hypothetical Role of ACE-2\Mas\BDNF Signaling Pathway
por: Motaghinejad, Majid, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5dab5bgmh49avpr1e32mr9lla0